The RNA-Seq data provided evidence (such as inhibition of the MAPK and NF-κB pathways) to support the local anti-inflammatory effect of leflunomide in the aortas and liver tissues of WD-fed ApoE-/- mice. Here, NFKB1 is linked to Wilson disease.